Scientists discover the symptoms of urinary tract cancer. This success can be helpful in finding a simple and better method of diagnosing this deadly disease.
Prostate cancer is one of the major causes of men’s deaths globally. The disease causes thousands of people annually, while millions of new cases are diagnosed.
However, diagnosis of early tumors in the body has been difficult due to lack of specific indicators.
At present, cancer is diagnosed using a blood test called PSA, which measures the protein rate of prostate gland.
Protein prostate-spasmic antigen (PSA) increases can indicate prostate cancer, but other non-cancerous qualities can be identified.
Now researchers have identified the right symptoms in the urine that can be very accurate to diagnose and diagnose prostate cancer and severity.
According to the latest research published in Journal Cancer Research, these symptoms (including molecules called Spon2, Amacr, and TMEFF2) are more accurate and specific in prostate cancer forecasts than PSA.
